Splenic lymphoma in a patient treated with interleukin-2 and dacarbazine for metastatic melanoma

Leuk Lymphoma. 1992 May;7(1-2):171-2. doi: 10.3109/10428199209053619.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Dacarbazine / adverse effects*
  • Dacarbazine / therapeutic use
  • Humans
  • Interleukin-2 / adverse effects*
  • Interleukin-2 / therapeutic use
  • Lymphatic Metastasis
  • Lymphoma / chemically induced*
  • Lymphoma / diagnosis
  • Male
  • Melanoma / pathology
  • Melanoma / surgery
  • Melanoma / therapy*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Skin Neoplasms / therapy*
  • Splenic Neoplasms / chemically induced*
  • Splenic Neoplasms / diagnosis

Substances

  • Interleukin-2
  • Dacarbazine